How to Navigate the Discount Rate Conundrum in Biotech and Pharma Valuation In the pharmaceutical and biotechnology industry (referred to collectively as biopharma), almost all valuation and investment decisions decisions…
How to Uncover Cost of Goods Sold (COGS) Insights with Pharma Competitive Intelligence COGS, aka the cost of goods sold, is one of the key intelligence questions that frequently emerge…
How to Conduct Robust Commercial Due Diligence by Looking Beyond Generics in Pharma Businesses Investors need to look beyond generics in the pharmaceutical commercial due diligence (CDD) for investment in…
Why Medical Conferences Are Critical for Pharma Competitive Intelligence Medical conferences (also referred to as medical congresses) are the holy grail for pharmaceutical competitive intelligence teams seeking to gain valuable…
Pharma and Diagnostics Competitive Intelligence: How to Anticipate Future Competitive intelligence (CI) is a commonly used decision-making tool in the pharmaceutical industry for seeking competitive advantage. It is often forward-looking…
How to Accurately Assess the True Addressable Market in Healthcare and Life Sciences Due Diligence Determining the appropriate addressable market is often one of the critical success factors in commercial…
How to Address Terminal Value Challenges in Pharmaceutical Asset Valuation Several stakeholders who have an interest in pharmaceutical assets employ a multitude of methods to conduct valuations. Among various valuation…
Win-win Investment Opportunities in Digital Health and IoT for Life Sciences Investors and Pharma Industry Digital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical companies. The…
A deep understanding of the key biotechnology valuation drivers is critical for those who have an interest in biotech assets and businesses- read how to conduct pharma and biotech valuation…